| FREE ARTICLE MORE > In an accompanying editorial, Steinhubl and Charnigo discuss optimal antiplatelet therapy in patients undergoing PCI. FREE ARTICLE MORE > JAMA-EXPRESS EARLY RELEASE Very High-Intensity Statin Therapy and Regression of Coronary Atherosclerosis To assess whether very intensive statin therapy could regress coronary atherosclerosis as determined by intravascular ultrasound (IVUS) imaging, Nissen and colleagues conducted the ASTEROID trial, a prospective, open-label blinded end-points trial in 507, of whom 349 had evaluable serial medical information IVUS examinations. Very high-intensity statin therapy resulted in significant regression of atherosclerosis medical information for all medical information 3 prespecified IVUS measures of disease burden. FREE ARTICLE MORE > In a related editorial, Blumenthal and Kapur discuss high-intensity statin therapy and the implications of this study for clinicians and future research. | pressrelease skyscape, being held from march 11 14, pre columbus american indians, explanation of american express membership rewards program, mexican american war mexico 1846, proud to be an american song lyrics, clinical practice, fujitsucomputer products of america, medical, american staffordshire terrier breeders nz, north american and american indians and three regions, nuclear medicine, |
|
| Significant benefits were observed in those receiving thrombolytic therapy and those not receiving any reperfusion therapy but not in those undergoing primary percutaneous coronary intervention. FREE ARTICLE MORE > Califf discusses these results and pre columbus american indians places them in context in an accompanying editorial. FREE ARTICLE MORE > JAMA-EXPRESS EARLY RELEASE Abciximab in Patients With Acute Coronary Syndromes Undergoing PCI After Clopidogrel Pretreatment To assess whether abciximab improves outcomes in high risk patients with non–ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention (PCI) after pretreatment pre columbus american indians with clopidogrel, Kastrati pre columbus american indians and colleagues conducted ISAR-REACT 2, a randomized, double blind, placebo-controlled study that enrolled 2022 patients. Patients assigned to receive abciximab experienced a relative 25% reduction in the composite primary end point of death, myocardial infarction, or urgent target vessel revascularization occurring within 30 days after randomization. |
![]() africa tour |
![]() namibia desert travel |
![]() tanzania travel |
![]() boat travel |
![]() bus travel |
![]() dating travel |
![]() egypt travel |
![]() europe travel |
![]() france tour |
![]() horse travel |
![]() last minute air ticket |
![]() car travel |
![]() travel bag |
![]() travel maps |